Deep Dream™ is your nightly switch from hustle to hush. This targeted blend pairs calming botanicals—Valerian and Passionflower—with focus-friendly L-Theanine and a gentle dose of melatonin to help quiet mental chatter, ease tension, and support a smooth transition into deep, restorative sleep. The result is a calmer mind and a relaxed body so you can drift off naturally and stay asleep longer.
Designed for Sleep, Recovery, Relaxation - Deep Dream™ supports the body’s overnight repair so you wake up clear, composed, and ready to move. Make it part of your wind-down ritual—dim the lights, breathe, and let the formula do the rest. No hype, no heavy sedatives—just steady, restorative nights that set up stronger days.
Other Ingredients: Vegetable Cellulose (Veggie Capsule)
Take one serving 30–60 minutes before bed as part of your wind-down routine; first-time users should start with the lowest suggested dose to gauge sensitivity. Use nightly or as needed, and avoid alcohol or operating machinery near bedtime.
Every Organica product is crafted with a purity-first promise—100% plant-based, vegan, and free from GMOs, fillers, and artificial additives. Each batch is third-party tested to ensure clean, effective wellness you can trust in every capsule.
Enhances deep sleep phases and REM cycles for more complete, uninterrupted overnight physical restoration.
Soothes tension in the nervous system to create the ideal state for falling asleep naturally and peacefully.
Encourages faster sleep onset by calming the mind and easing the body into deep, sustained rest.
Helps regulate circadian rhythm and promote more natural, consistent nightly rest patterns over time.
Helps reduce fatigue and mental heaviness by calming the nervous system and nourishing resilience.
Allows you to rise restored and recharged, without grogginess, mental fog, or daytime sluggishness.
Encourages faster sleep onset by calming the mind and easing the body into deep, sustained rest.
Enhances deep sleep phases and REM cycles for more complete, uninterrupted overnight physical restoration.
Soothes tension in the nervous system to create the ideal state for falling asleep naturally and peacefully.
Helps regulate circadian rhythm and promote more natural, consistent nightly rest patterns over time.
Helps reduce fatigue and mental heaviness by calming the nervous system and nourishing resilience.
Allows you to rise restored and recharged, without grogginess, mental fog, or daytime sluggishness.
Classic sleep botanical for faster onset and deeper continuity.
Origin: Valerian (Valeriana officinalis) — standardized root extract used to improve sleep, promote relaxation, deepen rest, enhance next-morning refreshment, support mental restoration, and help stabilize sleep rhythm. Modern extracts declare valerenic acids (e.g., ≥0.8%) and a DER (drug–extract ratio) for clinical equivalence.
Phytochemical Profile
1) Sleep Onset (latency ↓)
Randomized, placebo-controlled trials show shorter time to fall asleep with standardized valerian at bedtime vs placebo.
Study chips: 300–600 mg extract • 2–6 weeks or acute • Endpoints sleep latency (PSG/diaries) • DB-RCTs/meta-analyses.
2) Sleep Quality & Depth
Trials report better global sleep quality, fewer nocturnal awakenings, and higher subjective depth, especially when paired with hops.
Study chips: 300–600 mg • 2–8 weeks • Endpoints PSQI, awakenings, sleep depth/continuity • DB-RCTs/controlled.
3) Next-Morning Refreshment (sleep inertia ↓)
Participants often note clearer morning head and less grogginess vs sedative drugs; valerian favors physiologic sleep architecture.
Study chips: bedtime dosing • acute to 4–6 weeks • Endpoints morning vigor, sleep inertia scales • Controlled.
4) Relaxation & Pre-sleep Tension ↓
Valerian reduces somatic tension and restlessness, easing the transition to sleep; benefits extend to anxious sleepers.
Study chips: 300–600 mg • 2–4 weeks • Endpoints tension/anxiety VAS, STAI • DB-RCTs.
5) Rhythm Support (consistency over weeks)
With nightly use, studies show more consistent sleep–wake timing and improved self-rated regularity, aiding circadian stabilization.
Study chips: bedtime nightly • 4–8 weeks • Endpoints sleep timing variability, PSQI components • Controlled.
https://www.sleepjournal.org/
• https://www.journals.elsevier.com/phytomedicine
• https://onlinelibrary.wiley.com/journal/10991573
https://journals.sagepub.com/home/jop
• https://onlinelibrary.wiley.com/journal/10991077
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
Regulatory note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. Cautions: may enhance sedatives/alcohol—do not drive after dosing. Avoid during pregnancy/nursing. Rare paradoxical stimulation or GI upset can occur. Liver disease: use caution (rare case reports, often with multi-herb combinations). Use with clinician guidance if on CNS depressants.
Polyphenols that support efficient, restorative sleep.
Origin: Tart Cherry (Prunus cerasus, Montmorency) — fruit concentrate/extract used to improve sleep, promote relaxation, deepen rest, awaken refreshed, support mental restoration, and help stabilize circadian rhythm. We use low-sugar 10:1 concentrate powder or standardized extract with declared anthocyanins and polyphenols (and naturally occurring melatonin/tryptophan).
Phytochemical Profile
1) Sleep Duration & Efficiency (latency and awakenings ↓)
Randomized, placebo-controlled trials using tart-cherry concentrate show longer total sleep time, better sleep efficiency, and shorter time to fall asleep, with fewer night awakenings.
Study chips: ~240–480 mL/day juice or 500–1,000 mg/day powder equivalents (split dosing) • 1–2 weeks • Endpoints TST, SE, SOL, awakenings, PSQI/Insomnia scales • DB-RCTs.
2) Melatonin Physiology & Rhythm Support
Human studies report higher urinary 6-sulfatoxymelatonin and improved sleep–wake timing, consistent with circadian stabilization (use at consistent times).
Study chips: same ranges • 7–14 days • Endpoints aMT6s, actigraphy timing indices • RCTs/controlled.
3) Awaken Refreshed & Daytime Function
Across trials, participants report less sleep inertia and better next-day alertness/mood, aligning with cleaner sleep architecture versus sedative drugs.
Study chips: bedtime or split dosing • 1–2 weeks • Endpoints morning vigor, POMS/PANAS, subjective refreshment • Controlled.
4) Relaxation & Deep Rest via Recovery Pathways
Antioxidant/anti-inflammatory signals (anthocyanins/polyphenols) correlate with reduced muscle soreness and calmer nervous system tone, which helps deepen non-REM quality and mental restoration.
Study chips: 500–1,000 mg/day powder or juice equivalents • 4–14 days • Endpoints DOMS, CK/TBARS, sleep quality composites • DB-RCTs/controlled.
5) Tolerability & Metabolic Friendliness
When delivered as low-sugar concentrate powder, tart cherry is well tolerated and friendly for nightly use; studies note no next-day hangover and good GI tolerance at capsule doses.
Study chips: 500–1,000 mg/day powder • 1–2+ weeks • Endpoints AEs, morning function • Controlled.
https://link.springer.com/journal/394
• https://www.mdpi.com/journal/nutrients
https://www.liebertpub.com/journals/jmf
• https://www.tandfonline.com/toc/uacn20/current
https://link.springer.com/journal/40279
• https://cdnsciencepub.com/journal/apnm
https://www.mdpi.com/journal/antioxidants
• https://www.mdpi.com/journal/molecules
https://onlinelibrary.wiley.com/journal/10991573
• https://www.journals.elsevier.com/phytomedicine
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Generally well tolerated; juice forms can contain sugars/sorbitol (GI sensitivity). Mild antiplatelet potential from polyphenols—consult a clinician if on anticoagulants/antiplatelets. Avoid if allergic to cherries.
Rapid body and mind relaxation via GABA-A support.
Origin: Magnolia Bark (Magnolia officinalis) — standardized bark extract used to promote relaxation, improve sleep quality, deepen rest, enhance next-morning refreshment, support mental restoration, and help stabilize sleep rhythm. (People often say “Mongolian bark,” but the ingredient is Magnolia bark.) We use solvent-controlled extracts standardized for honokiol/magnolol.
Phytochemical Profile
1) Stress Reduction & Cortisol Modulation
Randomized, placebo-controlled human studies (often Magnolia + Phellodendron complex) show lower perceived stress, reduced salivary cortisol, and improved tension/irritability—a foundation for smoother sleep onset.
Study chips: 200–500 mg/day (standardized extracts; Magnolia often combined) • 4–8 weeks • Endpoints PSS, cortisol, mood scales • DB-RCTs.
2) Sleep Quality & Depth (awakening refreshment ↑)
Controlled trials report better global sleep quality, fewer nocturnal awakenings, and improved next-morning vigor, particularly in stressed adults using Magnolia-based formulas.
Study chips: ~120–300 mg Magnolia/day (alone or in combo) • 2–8 weeks • Endpoints PSQI, sleep diaries, morning vigor • DB-RCTs/controlled.
3) Relaxation & Pre-Sleep Calm
Human data show reductions in anxiety/tension and easier relaxation near bedtime; preclinical work confirms GABA_A facilitation without strong motor impairment.
Study chips: single dose → 4 weeks • Endpoints STAI, VAS calmness/tension • DB-RCTs/pilots + translational.
4) Deep Rest & Nighttime Continuity (adjacent markers)
With calmer arousal systems and antioxidant tone, participants experience more continuous non-REM feel and less restlessness, especially when Magnolia is paired with valerian/hops or lemon balm/passionflower.
Study chips: 2–8 weeks • Endpoints awakenings, sleep continuity components • Controlled.
5) Mental Restoration & Day-After Clarity
By lowering overnight arousal and oxidative “noise,” Magnolia supports clearer morning head and less sleep inertia than sedative drugs.
Study chips: 2–8 weeks • Endpoints morning affect/clarity, daytime sleepiness scales • Controlled.
https://www.journals.elsevier.com/phytomedicine
• https://onlinelibrary.wiley.com/journal/10991573
https://www.tandfonline.com/toc/uacn20/current
• https://nutritionj.biomedcentral.com/
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
https://www.mdpi.com/journal/ijms
• https://www.frontiersin.org/journals/pharmacology
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
Regulatory note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. May enhance sedatives/alcohol—do not drive after dosing. Avoid in pregnancy/nursing. Use caution with CNS depressants and discuss with a clinician if on complex meds.
Powerfully quiets the nervous system and provides rest.
Origin: Hops (Humulus lupulus) — standardized strobile (flower) extract used to promote relaxation, improve sleep quality, deepen rest, awaken refreshed, support mental restoration, and help stabilize sleep rhythm. We use solvent-controlled extracts with declared bitter acids (α/β) and prenylflavonoids (e.g., xanthohumol).
Phytochemical Profile
1) Sleep Onset (latency ↓)
Randomized, placebo-controlled trials—especially valerian + hops combos—show shorter time to fall asleep compared with placebo.
Study chips: 100–200 mg/day hops extract (often with 300–600 mg valerian) • 2–6 weeks or acute • Endpoints SOL (sleep latency), sleep diaries • DB-RCTs/controlled.
2) Sleep Quality & Night Continuity
Trials report better global sleep quality, fewer nocturnal awakenings, and calmer night rest, with favorable next-day function.
Study chips: doses as above • 2–8 weeks • Endpoints PSQI, awakenings, sleep continuity indices • DB-RCTs/controlled.
3) Relaxation & Pre-sleep Tension ↓
Human studies note reduced somatic tension and anxious arousal prior to bedtime, easing transition into sleep.
Study chips: single dose → 4 weeks • Endpoints STAI / VAS tension–calmness • DB-RCTs/pilots.
4) Awaken Refreshed (sleep inertia ↓)
Compared with sedative drugs, hops-based formulas are associated with clearer morning head and less sleep inertia, aligning with physiologic sleep architecture.
Study chips: bedtime use • acute to 4–6 weeks • Endpoints morning vigor, daytime sleepiness scales • Controlled.
5) Rhythm Support & Stress Physiology
By lowering evening arousal (GABAergic + antioxidant/anti-inflammatory actions), consistent use helps stabilize sleep–wake timing and reduces stress-linked sleep disruption.
Study chips: nightly dosing • 4–8 weeks • Endpoints PSQI components, timing variability, HR/BP under stress • Controlled.
https://www.journals.elsevier.com/phytomedicine
• https://onlinelibrary.wiley.com/journal/10991573
https://www.sleepjournal.org/
• https://journals.sagepub.com/home/jop
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
• https://www.mdpi.com/journal/molecules
https://www.mdpi.com/journal/ijms
• https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
Regulatory note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. Cautions: may enhance sedatives/alcohol—do not drive after dosing. Avoid in pregnancy/nursing. Because hops contains mild phytoestrogens (8-prenylnaringenin), use clinician guidance with estrogen-sensitive conditions or hormonal therapies. Possible allergy in those sensitive to Cannabaceae (hops/hemp).
Origin: Kava (Piper methysticum) — standardized root extract used to promote relaxation, improve sleep quality, deepen rest, reduce pre-sleep tension, support mental restoration, and help stabilize sleep rhythm—primarily via robust anxiolytic effects. We use root-only extracts, standardized for kavalactones (kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, desmethoxyyangonin).
Phytochemical Profile
1) Clinically meaningful anxiolysis
Multiple double-blind RCTs and meta-analyses show significant reductions in anxiety scores versus placebo with standardized kava—often comparable to low-dose benzodiazepines for mild–moderate anxiety, but without cognitive dulling.
Study chips: provides ~120–250 mg/day total kavalactones • 2–8+ weeks • Endpoints HAM-A, STAI, PSWQ • DB-RCTs/meta-analyses.
2) Sleep onset & quality (via reduced arousal)
In anxious or stressed sleepers, kava shortens sleep latency and improves global sleep quality (fewer nighttime awakenings, better next-day refreshment).
Study chips: evening dosing within ranges above • 2–6 weeks • Endpoints PSQI, SOL, awakenings, morning vigor • DB-RCTs/controlled.
3) Pre-bed relaxation & muscle tension ↓
Trials and controlled series report reduced somatic tension, restlessness, and rumination, easing the transition to deep rest.
Study chips: single dose → 4 weeks • Endpoints VAS calmness/tension, STAI-State • DB-RCTs/pilots.
4) Circadian rhythm support (indirect)
By damping evening hyperarousal, consistent nightly use helps stabilize sleep–wake timing and reduces stress-linked phase delays.
Study chips: nightly dosing • 2–8+ weeks • Endpoints PSQI components, sleep timing variability • Controlled.
5) Next-day mental restoration (hangover-sparing)
Compared with sedative hypnotics, kava regimens show clearer morning head and less sleep inertia, preserving cognition and mood.
Study chips: bedtime dosing • acute to 4–6 weeks • Endpoints POMS/PANAS, daytime sleepiness • Controlled.
https://onlinelibrary.wiley.com/journal/10991573
• https://www.journals.elsevier.com/phytomedicine
https://journals.lww.com/psychopharmacology
• https://link.springer.com/journal/213
https://www.mdpi.com/journal/nutrients
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
• https://www.frontiersin.org/journals/pharmacology
https://www.sleepjournal.org/
• https://www.sciencedirect.com/journal/complementary-therapies-in-medicine
Regulatory & Safety note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. Liver caution (rare, idiosyncratic): avoid with liver disease, heavy alcohol, or hepatotoxic drugs/supplements; stop and seek care if dark urine, jaundice, RUQ pain, or unusual fatigue occur. Do not combine with alcohol or sedatives (additive CNS depression). Avoid in pregnancy/nursing. Use under clinician guidance if on CNS depressants, antiplatelets/anticoagulants, or complex meds.
Origin: Passionflower (Passiflora incarnata) — standardized aerial-part extract used for stress reduction, mood stabilization, calm-alert focus, mental restoration (sleep quality), and supportive mental clarity. We use leaf/flower extracts standardized for vitexin/isovitexin flavonoids (e.g., ≥3.5% vitexin), not essential oils.
Phytochemical Profile
1) Anxiety & Perceived Stress Reduction
Randomized, placebo-controlled trials show lower state anxiety and perceived stress with standardized passionflower versus placebo; effect sizes are small-to-moderate and “feelable” within days.
Study chips: 200–600 mg/day extract (3.5–4% vitexin or total flavonoids) • 2–8 weeks • Endpoints STAI-State, PSS, VAS calm/tension • DB-RCTs/meta-analyses.
2) Sleep Quality & Next-Day Calm
Controlled studies report better sleep quality (sleep latency ↓, night awakenings ↓, global sleep scores ↑) and improved next-day calmness/clarity.
Study chips: 300–600 mg/day • 2–8 weeks (or evening acute) • Endpoints PSQI, sleep diaries, morning affect • DB-RCTs/controlled.
3) Mood Stabilization (tension/irritability ↓)
Trials note reduced irritability and somatic tension, with improved well-being—useful across luteal-phase or high-stress periods.
Study chips: 200–600 mg/day • 4–8 weeks • Endpoints POMS/PANAS, global mood • DB-RCTs.
4) Focus Under Pressure (calm-alert attention)
By lowering anxious arousal without sedation, passionflower supports sustained attention and task accuracy in stress-provoking settings—best when paired with L-theanine or Rhodiola.
Study chips: 200–400 mg acute/short course • Endpoints vigilance/WM accuracy, RT under stress • Controlled studies.
5) Physiologic Stress Markers (supportive)
Human data show gentler HR/BP responses during acute stress and directionally lower cortisol, aligning with GABAergic and anti-inflammatory actions.
Study chips: 300–600 mg/day • 2–8 weeks • Endpoints HR/BP under stress, salivary cortisol • Randomized/controlled.
https://onlinelibrary.wiley.com/journal/10991573
• https://www.journals.elsevier.com/phytomedicine
https://journals.sagepub.com/home/jop
• https://onlinelibrary.wiley.com/journal/10991077
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
https://www.sciencedirect.com/journal/complementary-therapies-in-medicine
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Cautions: may enhance sedatives/alcohol; use care with benzodiazepines, barbiturates, or CNS depressants. Avoid in pregnancy. If on complex medications (especially CNS-active), consult a clinician.
Origin: Lemon Balm (Melissa officinalis) — standardized leaf extract used for mental clarity, stress reduction, focus, mood stabilization, and mental restoration (sleep quality). We use solvent-controlled leaf extracts (not essential oil), typically standardized for rosmarinic acid (and related polyphenols).
Phytochemical Profile
1) Stress & Anxiety Reduction
Randomized, placebo-controlled trials show lower state anxiety and perceived stress with lemon balm extracts versus placebo—often with feelable calm within hours (acute) and stronger effects over weeks.
Study chips: 300–600 mg (acute) or 200–600 mg/day • Acute to 2–8 wk • Endpoints STAI-State, PSS, VAS calmness/tension • DB-RCTs.
2) Calm-Alert Focus & Attention
Human studies report improved sustained attention/working-memory accuracy and reduced mental fatigue, reflecting combined GABA and cholinergic actions—“calm focus” without sedation.
Study chips: 300–600 mg acute; 200–300 mg/day for weeks • Endpoints RVIP, working memory, reaction time & accuracy • DB-RCTs/crossover.
3) Mood Stabilization & Well-Being
Trials note tension/irritability ↓ and contentedness ↑, supporting steadier mood across the workday.
Study chips: 200–600 mg/day • 2–8 wk • Endpoints POMS/PANAS, VAS mood • DB-RCTs.
4) Mental Restoration (Sleep Quality)
Evening or twice-daily dosing is associated with better sleep quality (latency ↓, disturbances ↓) and next-day calmness/clarity, especially in stressed adults.
Study chips: 200–600 mg/day • 4–8 wk • Endpoints PSQI, sleep diaries, morning affect • Controlled trials.
5) Physiologic Stress Markers
Controlled studies show gentler HR/BP responses during acute stress and directionally lower cortisol in some cohorts—consistent with HPA-axis modulation.
Study chips: 300–600 mg acute or 200–600 mg/day • Acute to 4–8 wk • Endpoints HR/BP under stress, salivary cortisol • Randomized/controlled.
https://onlinelibrary.wiley.com/journal/10991573
https://journals.sagepub.com/home/jop
https://www.mdpi.com/journal/nutrients
https://www.hindawi.com/journals/ecam/
• https://www.sciencedirect.com/journal/complementary-therapies-in-medicine
https://www.mdpi.com/journal/ijms
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. May enhance effects of sedatives; use caution with alcohol/CNS depressants. Avoid during pregnancy. If hypothyroid and medicated, consult a clinician.
Origin: Kava (Piper methysticum) — standardized root extract used to promote relaxation, improve sleep quality, deepen rest, reduce pre-sleep tension, support mental restoration, and help stabilize sleep rhythm—primarily via robust anxiolytic effects. We use root-only extracts, standardized for kavalactones (kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, desmethoxyyangonin).
Phytochemical Profile
1) Clinically meaningful anxiolysis
Multiple double-blind RCTs and meta-analyses show significant reductions in anxiety scores versus placebo with standardized kava—often comparable to low-dose benzodiazepines for mild–moderate anxiety, but without cognitive dulling.
Study chips: provides ~120–250 mg/day total kavalactones • 2–8+ weeks • Endpoints HAM-A, STAI, PSWQ • DB-RCTs/meta-analyses.
2) Sleep onset & quality (via reduced arousal)
In anxious or stressed sleepers, kava shortens sleep latency and improves global sleep quality (fewer nighttime awakenings, better next-day refreshment).
Study chips: evening dosing within ranges above • 2–6 weeks • Endpoints PSQI, SOL, awakenings, morning vigor • DB-RCTs/controlled.
3) Pre-bed relaxation & muscle tension ↓
Trials and controlled series report reduced somatic tension, restlessness, and rumination, easing the transition to deep rest.
Study chips: single dose → 4 weeks • Endpoints VAS calmness/tension, STAI-State • DB-RCTs/pilots.
4) Circadian rhythm support (indirect)
By damping evening hyperarousal, consistent nightly use helps stabilize sleep–wake timing and reduces stress-linked phase delays.
Study chips: nightly dosing • 2–8+ weeks • Endpoints PSQI components, sleep timing variability • Controlled.
5) Next-day mental restoration (hangover-sparing)
Compared with sedative hypnotics, kava regimens show clearer morning head and less sleep inertia, preserving cognition and mood.
Study chips: bedtime dosing • acute to 4–6 weeks • Endpoints POMS/PANAS, daytime sleepiness • Controlled.
https://onlinelibrary.wiley.com/journal/10991573
• https://www.journals.elsevier.com/phytomedicine
https://journals.lww.com/psychopharmacology
• https://link.springer.com/journal/213
https://www.mdpi.com/journal/nutrients
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
• https://www.frontiersin.org/journals/pharmacology
https://www.sleepjournal.org/
• https://www.sciencedirect.com/journal/complementary-therapies-in-medicine
Regulatory & Safety note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. Liver caution (rare, idiosyncratic): avoid with liver disease, heavy alcohol, or hepatotoxic drugs/supplements; stop and seek care if dark urine, jaundice, RUQ pain, or unusual fatigue occur. Do not combine with alcohol or sedatives (additive CNS depression). Avoid in pregnancy/nursing. Use under clinician guidance if on CNS depressants, antiplatelets/anticoagulants, or complex meds.
Origin: Magnolia Bark (Magnolia officinalis) — standardized bark extract used to promote relaxation, improve sleep quality, deepen rest, enhance next-morning refreshment, support mental restoration, and help stabilize sleep rhythm. (People often say “Mongolian bark,” but the ingredient is Magnolia bark.) We use solvent-controlled extracts standardized for honokiol/magnolol.
Phytochemical Profile
1) Stress Reduction & Cortisol Modulation
Randomized, placebo-controlled human studies (often Magnolia + Phellodendron complex) show lower perceived stress, reduced salivary cortisol, and improved tension/irritability—a foundation for smoother sleep onset.
Study chips: 200–500 mg/day (standardized extracts; Magnolia often combined) • 4–8 weeks • Endpoints PSS, cortisol, mood scales • DB-RCTs.
2) Sleep Quality & Depth (awakening refreshment ↑)
Controlled trials report better global sleep quality, fewer nocturnal awakenings, and improved next-morning vigor, particularly in stressed adults using Magnolia-based formulas.
Study chips: ~120–300 mg Magnolia/day (alone or in combo) • 2–8 weeks • Endpoints PSQI, sleep diaries, morning vigor • DB-RCTs/controlled.
3) Relaxation & Pre-Sleep Calm
Human data show reductions in anxiety/tension and easier relaxation near bedtime; preclinical work confirms GABA_A facilitation without strong motor impairment.
Study chips: single dose → 4 weeks • Endpoints STAI, VAS calmness/tension • DB-RCTs/pilots + translational.
4) Deep Rest & Nighttime Continuity (adjacent markers)
With calmer arousal systems and antioxidant tone, participants experience more continuous non-REM feel and less restlessness, especially when Magnolia is paired with valerian/hops or lemon balm/passionflower.
Study chips: 2–8 weeks • Endpoints awakenings, sleep continuity components • Controlled.
5) Mental Restoration & Day-After Clarity
By lowering overnight arousal and oxidative “noise,” Magnolia supports clearer morning head and less sleep inertia than sedative drugs.
Study chips: 2–8 weeks • Endpoints morning affect/clarity, daytime sleepiness scales • Controlled.
https://www.journals.elsevier.com/phytomedicine
• https://onlinelibrary.wiley.com/journal/10991573
https://www.tandfonline.com/toc/uacn20/current
• https://nutritionj.biomedcentral.com/
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
https://www.mdpi.com/journal/ijms
• https://www.frontiersin.org/journals/pharmacology
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
Regulatory note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. May enhance sedatives/alcohol—do not drive after dosing. Avoid in pregnancy/nursing. Use caution with CNS depressants and discuss with a clinician if on complex meds.
Origin: Tart Cherry (Prunus cerasus, Montmorency) — fruit concentrate/extract used to improve sleep, promote relaxation, deepen rest, awaken refreshed, support mental restoration, and help stabilize circadian rhythm. We use low-sugar 10:1 concentrate powder or standardized extract with declared anthocyanins and polyphenols (and naturally occurring melatonin/tryptophan).
Phytochemical Profile
1) Sleep Duration & Efficiency (latency and awakenings ↓)
Randomized, placebo-controlled trials using tart-cherry concentrate show longer total sleep time, better sleep efficiency, and shorter time to fall asleep, with fewer night awakenings.
Study chips: ~240–480 mL/day juice or 500–1,000 mg/day powder equivalents (split dosing) • 1–2 weeks • Endpoints TST, SE, SOL, awakenings, PSQI/Insomnia scales • DB-RCTs.
2) Melatonin Physiology & Rhythm Support
Human studies report higher urinary 6-sulfatoxymelatonin and improved sleep–wake timing, consistent with circadian stabilization (use at consistent times).
Study chips: same ranges • 7–14 days • Endpoints aMT6s, actigraphy timing indices • RCTs/controlled.
3) Awaken Refreshed & Daytime Function
Across trials, participants report less sleep inertia and better next-day alertness/mood, aligning with cleaner sleep architecture versus sedative drugs.
Study chips: bedtime or split dosing • 1–2 weeks • Endpoints morning vigor, POMS/PANAS, subjective refreshment • Controlled.
4) Relaxation & Deep Rest via Recovery Pathways
Antioxidant/anti-inflammatory signals (anthocyanins/polyphenols) correlate with reduced muscle soreness and calmer nervous system tone, which helps deepen non-REM quality and mental restoration.
Study chips: 500–1,000 mg/day powder or juice equivalents • 4–14 days • Endpoints DOMS, CK/TBARS, sleep quality composites • DB-RCTs/controlled.
5) Tolerability & Metabolic Friendliness
When delivered as low-sugar concentrate powder, tart cherry is well tolerated and friendly for nightly use; studies note no next-day hangover and good GI tolerance at capsule doses.
Study chips: 500–1,000 mg/day powder • 1–2+ weeks • Endpoints AEs, morning function • Controlled.
https://link.springer.com/journal/394
• https://www.mdpi.com/journal/nutrients
https://www.liebertpub.com/journals/jmf
• https://www.tandfonline.com/toc/uacn20/current
https://link.springer.com/journal/40279
• https://cdnsciencepub.com/journal/apnm
https://www.mdpi.com/journal/antioxidants
• https://www.mdpi.com/journal/molecules
https://onlinelibrary.wiley.com/journal/10991573
• https://www.journals.elsevier.com/phytomedicine
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Generally well tolerated; juice forms can contain sugars/sorbitol (GI sensitivity). Mild antiplatelet potential from polyphenols—consult a clinician if on anticoagulants/antiplatelets. Avoid if allergic to cherries.
Origin: Hops (Humulus lupulus) — standardized strobile (flower) extract used to promote relaxation, improve sleep quality, deepen rest, awaken refreshed, support mental restoration, and help stabilize sleep rhythm. We use solvent-controlled extracts with declared bitter acids (α/β) and prenylflavonoids (e.g., xanthohumol).
Phytochemical Profile
1) Sleep Onset (latency ↓)
Randomized, placebo-controlled trials—especially valerian + hops combos—show shorter time to fall asleep compared with placebo.
Study chips: 100–200 mg/day hops extract (often with 300–600 mg valerian) • 2–6 weeks or acute • Endpoints SOL (sleep latency), sleep diaries • DB-RCTs/controlled.
2) Sleep Quality & Night Continuity
Trials report better global sleep quality, fewer nocturnal awakenings, and calmer night rest, with favorable next-day function.
Study chips: doses as above • 2–8 weeks • Endpoints PSQI, awakenings, sleep continuity indices • DB-RCTs/controlled.
3) Relaxation & Pre-sleep Tension ↓
Human studies note reduced somatic tension and anxious arousal prior to bedtime, easing transition into sleep.
Study chips: single dose → 4 weeks • Endpoints STAI / VAS tension–calmness • DB-RCTs/pilots.
4) Awaken Refreshed (sleep inertia ↓)
Compared with sedative drugs, hops-based formulas are associated with clearer morning head and less sleep inertia, aligning with physiologic sleep architecture.
Study chips: bedtime use • acute to 4–6 weeks • Endpoints morning vigor, daytime sleepiness scales • Controlled.
5) Rhythm Support & Stress Physiology
By lowering evening arousal (GABAergic + antioxidant/anti-inflammatory actions), consistent use helps stabilize sleep–wake timing and reduces stress-linked sleep disruption.
Study chips: nightly dosing • 4–8 weeks • Endpoints PSQI components, timing variability, HR/BP under stress • Controlled.
https://www.journals.elsevier.com/phytomedicine
• https://onlinelibrary.wiley.com/journal/10991573
https://www.sleepjournal.org/
• https://journals.sagepub.com/home/jop
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
• https://www.mdpi.com/journal/molecules
https://www.mdpi.com/journal/ijms
• https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
Regulatory note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. Cautions: may enhance sedatives/alcohol—do not drive after dosing. Avoid in pregnancy/nursing. Because hops contains mild phytoestrogens (8-prenylnaringenin), use clinician guidance with estrogen-sensitive conditions or hormonal therapies. Possible allergy in those sensitive to Cannabaceae (hops/hemp).
Origin: Valerian (Valeriana officinalis) — standardized root extract used to improve sleep, promote relaxation, deepen rest, enhance next-morning refreshment, support mental restoration, and help stabilize sleep rhythm. Modern extracts declare valerenic acids (e.g., ≥0.8%) and a DER (drug–extract ratio) for clinical equivalence.
Phytochemical Profile
1) Sleep Onset (latency ↓)
Randomized, placebo-controlled trials show shorter time to fall asleep with standardized valerian at bedtime vs placebo.
Study chips: 300–600 mg extract • 2–6 weeks or acute • Endpoints sleep latency (PSG/diaries) • DB-RCTs/meta-analyses.
2) Sleep Quality & Depth
Trials report better global sleep quality, fewer nocturnal awakenings, and higher subjective depth, especially when paired with hops.
Study chips: 300–600 mg • 2–8 weeks • Endpoints PSQI, awakenings, sleep depth/continuity • DB-RCTs/controlled.
3) Next-Morning Refreshment (sleep inertia ↓)
Participants often note clearer morning head and less grogginess vs sedative drugs; valerian favors physiologic sleep architecture.
Study chips: bedtime dosing • acute to 4–6 weeks • Endpoints morning vigor, sleep inertia scales • Controlled.
4) Relaxation & Pre-sleep Tension ↓
Valerian reduces somatic tension and restlessness, easing the transition to sleep; benefits extend to anxious sleepers.
Study chips: 300–600 mg • 2–4 weeks • Endpoints tension/anxiety VAS, STAI • DB-RCTs.
5) Rhythm Support (consistency over weeks)
With nightly use, studies show more consistent sleep–wake timing and improved self-rated regularity, aiding circadian stabilization.
Study chips: bedtime nightly • 4–8 weeks • Endpoints sleep timing variability, PSQI components • Controlled.
https://www.sleepjournal.org/
• https://www.journals.elsevier.com/phytomedicine
• https://onlinelibrary.wiley.com/journal/10991573
https://journals.sagepub.com/home/jop
• https://onlinelibrary.wiley.com/journal/10991077
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
Regulatory note: Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent disease. Cautions: may enhance sedatives/alcohol—do not drive after dosing. Avoid during pregnancy/nursing. Rare paradoxical stimulation or GI upset can occur. Liver disease: use caution (rare case reports, often with multi-herb combinations). Use with clinician guidance if on CNS depressants.
Origin: Passionflower (Passiflora incarnata) — standardized aerial-part extract used for stress reduction, mood stabilization, calm-alert focus, mental restoration (sleep quality), and supportive mental clarity. We use leaf/flower extracts standardized for vitexin/isovitexin flavonoids (e.g., ≥3.5% vitexin), not essential oils.
Phytochemical Profile
1) Anxiety & Perceived Stress Reduction
Randomized, placebo-controlled trials show lower state anxiety and perceived stress with standardized passionflower versus placebo; effect sizes are small-to-moderate and “feelable” within days.
Study chips: 200–600 mg/day extract (3.5–4% vitexin or total flavonoids) • 2–8 weeks • Endpoints STAI-State, PSS, VAS calm/tension • DB-RCTs/meta-analyses.
2) Sleep Quality & Next-Day Calm
Controlled studies report better sleep quality (sleep latency ↓, night awakenings ↓, global sleep scores ↑) and improved next-day calmness/clarity.
Study chips: 300–600 mg/day • 2–8 weeks (or evening acute) • Endpoints PSQI, sleep diaries, morning affect • DB-RCTs/controlled.
3) Mood Stabilization (tension/irritability ↓)
Trials note reduced irritability and somatic tension, with improved well-being—useful across luteal-phase or high-stress periods.
Study chips: 200–600 mg/day • 4–8 weeks • Endpoints POMS/PANAS, global mood • DB-RCTs.
4) Focus Under Pressure (calm-alert attention)
By lowering anxious arousal without sedation, passionflower supports sustained attention and task accuracy in stress-provoking settings—best when paired with L-theanine or Rhodiola.
Study chips: 200–400 mg acute/short course • Endpoints vigilance/WM accuracy, RT under stress • Controlled studies.
5) Physiologic Stress Markers (supportive)
Human data show gentler HR/BP responses during acute stress and directionally lower cortisol, aligning with GABAergic and anti-inflammatory actions.
Study chips: 300–600 mg/day • 2–8 weeks • Endpoints HR/BP under stress, salivary cortisol • Randomized/controlled.
https://onlinelibrary.wiley.com/journal/10991573
• https://www.journals.elsevier.com/phytomedicine
https://journals.sagepub.com/home/jop
• https://onlinelibrary.wiley.com/journal/10991077
https://www.mdpi.com/journal/nutrients
• https://www.mdpi.com/journal/antioxidants
https://www.sciencedirect.com/journal/journal-of-ethnopharmacology
https://www.sciencedirect.com/journal/complementary-therapies-in-medicine
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Cautions: may enhance sedatives/alcohol; use care with benzodiazepines, barbiturates, or CNS depressants. Avoid in pregnancy. If on complex medications (especially CNS-active), consult a clinician.
Origin: Lemon Balm (Melissa officinalis) — standardized leaf extract used for mental clarity, stress reduction, focus, mood stabilization, and mental restoration (sleep quality). We use solvent-controlled leaf extracts (not essential oil), typically standardized for rosmarinic acid (and related polyphenols).
Phytochemical Profile
1) Stress & Anxiety Reduction
Randomized, placebo-controlled trials show lower state anxiety and perceived stress with lemon balm extracts versus placebo—often with feelable calm within hours (acute) and stronger effects over weeks.
Study chips: 300–600 mg (acute) or 200–600 mg/day • Acute to 2–8 wk • Endpoints STAI-State, PSS, VAS calmness/tension • DB-RCTs.
2) Calm-Alert Focus & Attention
Human studies report improved sustained attention/working-memory accuracy and reduced mental fatigue, reflecting combined GABA and cholinergic actions—“calm focus” without sedation.
Study chips: 300–600 mg acute; 200–300 mg/day for weeks • Endpoints RVIP, working memory, reaction time & accuracy • DB-RCTs/crossover.
3) Mood Stabilization & Well-Being
Trials note tension/irritability ↓ and contentedness ↑, supporting steadier mood across the workday.
Study chips: 200–600 mg/day • 2–8 wk • Endpoints POMS/PANAS, VAS mood • DB-RCTs.
4) Mental Restoration (Sleep Quality)
Evening or twice-daily dosing is associated with better sleep quality (latency ↓, disturbances ↓) and next-day calmness/clarity, especially in stressed adults.
Study chips: 200–600 mg/day • 4–8 wk • Endpoints PSQI, sleep diaries, morning affect • Controlled trials.
5) Physiologic Stress Markers
Controlled studies show gentler HR/BP responses during acute stress and directionally lower cortisol in some cohorts—consistent with HPA-axis modulation.
Study chips: 300–600 mg acute or 200–600 mg/day • Acute to 4–8 wk • Endpoints HR/BP under stress, salivary cortisol • Randomized/controlled.
https://onlinelibrary.wiley.com/journal/10991573
https://journals.sagepub.com/home/jop
https://www.mdpi.com/journal/nutrients
https://www.hindawi.com/journals/ecam/
• https://www.sciencedirect.com/journal/complementary-therapies-in-medicine
https://www.mdpi.com/journal/ijms
Regulatory note: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. May enhance effects of sedatives; use caution with alcohol/CNS depressants. Avoid during pregnancy. If hypothyroid and medicated, consult a clinician.
Natural Botanicals – Real plant extracts you can pronounce; no harmful ingrdients or chemicals
Natural Botanicals – Real plant extracts you can pronounce; no harmful ingrdients or chemicals
Multi-Angle Formulation - Cohesively crafted to deliver results from 6 different angles
Multi-Angle Formulation - Cohesively crafted to deliver results from 6 different angles
Proven Real Trials – Backed by extensive peer testing for effective, consistent results
Proven Real Trials – Backed by extensive peer testing for effective, consistent results
Clinically Researched – Backed by rigorous clinical data using only proven ingredients
Clinically Researched – Backed by rigorous clinical data using only proven ingredients
Optimal Bioavailability – Absorption-focused design for reliable uptake and persitant results
Optimal Bioavailability – Absorption-focused design for reliable uptake and persitant results
Ethical Sourcing – Supports small family farms, no industrial or exploitative suppliers
Ethical Sourcing – Supports small family farms, no industrial or exploitative suppliers
Glass & Bamboo Packaging – Eco-friendly packaging that protects purity, no harmful plastics
Glass & Bamboo Packaging – Eco-friendly packaging that protects purity, no harmful plastics
QR Code Verified – Scan to see your batch’s lab report and source trail, no hidden supply chains
QR Code Verified – Scan to see your batch’s lab report and source trail, no hidden supply chains
No Fillers or Additives - Clean formulation without fillers, artificial flavors, or harsh preservatives
No Fillers or Additives - Clean formulation without fillers, artificial flavors, or harsh preservatives
Vegan & Allergen-Free – No animal products, dairy, soy, gluten, or common allergens
Vegan & Allergen-Free – No animal products, dairy, soy, gluten, or common allergens
Deep Dream™ capsules deliver a targeted two-capsule bedtime serving: 3 mg fast-release melatonin (for sleep onset), 150 mg magnesium glycinate (for sleep quality), 100 mg L-Theanine (for relaxation), 200 mg Valerian root extract (standardized to ≥0.8 % valerenic acids), 50 mg GABA, and 100 mg Passionflower extract (standardized to ≥4 % rosmarinic acid). Each ingredient is third-party–tested to guarantee purity and consistent bioactive potency.
The fast-release 3 mg melatonin acts on melatonin receptors to signal night onset, shortening sleep latency by an average of 15 minutes in adults with primary insomnia during a 4-week trial .
Magnesium glycinate supplementation (150 mg nightly) enhances sleep efficiency, increases total sleep time by over 20 minutes, and reduces nighttime awakenings in adults with mild insomnia symptoms. Valerian root extract further decreases sleep-onset latency and enhances subjective sleep quality over 4–8 weeks.
L-Theanine (100 mg) boosts alpha-brain waves and eases mental tension, while Passionflower’s rosmarinic acid calms GABA pathways. In clinical studies, combined botanicals reduced anxiety scores by 20 % and improved sleep-related calmness within 4 weeks.
Take two capsules 30 minutes before bedtime with a glass of water. This timing aligns melatonin release and relaxant botanicals with your natural wind-down period, supporting seamless transition into restorative sleep.
Many users notice quicker sleep onset within the first night due to melatonin and L-Theanine. Improvements in sleep continuity and depth typically emerge by week 2–4, while full benefits on sleep quality and restfulness are usually realized after 6–8 weeks of nightly use.